Filter Results:
(993)
Show Results For
- All HBS Web
(993)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(993)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- Web
1.0 MBA Standards of Conduct | MBA
1.3.4 Classroom Recording, Photography & Social Media 1.3.5 Classroom Non-Attribution 1.3.6 Academic Retaliation 1.4 Community Standards of Conduct 1.4.1 Recruiting Standards of Conduct 1.4.2 Drug and Alcohol Policy 1.4.3 Anti-Hazing... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- 01 Dec 2019
- News
The Race Against Resistance
tide. “If we don’t take steps to slow down or stop drug resistance, we will fall back to a time when simple infections killed people. Can you imagine? That’s a bit of a doomsday perspective, but it’s a call to action.” “We are approaching... View Details
Keywords: Lisa Scanlon Mogolov
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company... View Details
Keywords: Healthcare
- 06 Oct 2020
- Blog Post
2+2 Where Are They Now Spotlight: Curtis Wu (MBA 2018)
Can you describe your role?I currently work at Amgen Inc at their global HQ in Southern California. Amgen is the largest independent biotechnology company in the world by revenue and our top medicines include autoimmune drug Enbrel, white... View Details
Randall L. Tobias
The first outsider to run the company, Tobias is credited with orchestrating a major turnaround of Eli Lilly. Under his direction, Lilly introduced two successful drugs (Zyprexa for schizophrenia and Gemzar for cancer), solidified and... View Details
Keywords: Healthcare
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based... View Details
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin... View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs crashed into the cocaine wars... View Details
- 01 Sep 2008
- News
Mara Aspinall
higher efficacy rate — 80 percent or more. Is 80 percent efficacy unusual for drugs currently on the market? Across all patients and diseases, drug efficacy averages 50 percent, so half the time they bring... View Details
Stanley P. Goldstein
In 1969, Goldstein’s drug store chain, CVS, was acquired by Melville Corporation and soon became the conglomerate’s dominant retail establishment. Goldstein took the reins of Melville in 1987 and began a total restructuring program... View Details
Keywords: Retail
- 10 Nov 2020
- Sharpening Your Skills
Research News and Tips: Innovating Across Time Zones
Dany Bahar, Prithwiraj Choudhury, and Britta Glennon. Drugs approved in December are associated with more adverse effects New research reveals that drug approvals surge in the US in December, at month-ends,... View Details
Keywords: by Sean Silverthorne
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks... View Details
Keywords: Margie Kelley
Robert F. Dee
During his CEO tenure, Dee achieved an 800% increase in revenues (over $3 billion) – moving SmithKline into the upper echelons of major pharmaceutical organizations. He introduced the anti-ulcer medication, Tagamet, which became the largest selling prescription View Details
Keywords: Healthcare
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- Web
1.4 Community Standards of Conduct | MBA
1.4 Community Standards of Conduct 1.0 MBA Standards of Conduct 1.4.1 Recruiting Standards of Conduct 1.4.2 Drug and Alcohol Policy 1.4.3 Anti-Hazing Policy 1.4.4 Dangerous Weapons and Threats 1.4.5 Physical Violence 1.4.6 Honesty,... View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
William B. Bell
coating resins, as well as melamine resins, which were used in making work surfaces impervious to scratches and stains. During the 1940s and 50s, Bell also expanded American Cyanamid's activities in drug research and production. View Details
Keywords: Chemicals & Industrial